Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cadranel

Showing results (611-620 of 709) with videos related to

Pageof 71
Sort By:
ESMO Open|December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancerO Molinier, B Besse, F Barlesi, et al.
Clinical Lung Cancer|October 26, 2019
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE TrialJaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, et al.
ERJ Open Research|October 13, 2016
Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national surveyVincent Cottin, Emmanuel Bergot, Arnaud Bourdin, et al.
Frontiers in Cell and Developmental Biology|October 28, 2021
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number AlterationsAmira Bouzidi, Karim Labreche, Marine Baron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) programC Leduc, J P Merlio, B Besse, et al.
The European Respiratory Journal|March 17, 2018
Cost-effectiveness of <i>KRAS</i>, <i>EGFR</i> and <i>ALK</i> testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm studySandrine Loubière, Alexandre Drezet, Michèle Beau-Faller, et al.
Frontiers in Immunology|August 10, 2019
Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 PatientsCindy Marques, Julien Carvelli, Lucie Biard, et al.
Respiratory Medicine and Research|May 17, 2020
Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST studyC Fontaine-Delaruelle, J Mazières, J Cadranel, et al.
Exploration of Digestive Diseases|April 9, 2026
Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and TreatmentIna Bergheim, Jean Francois Cadranel, Jian Guo Chen, et al.
Digestive Diseases and Sciences|January 29, 2016
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in FrancePatrick Marcellin, Fabien Zoulim, Christophe Hézode, et al.
Pageof 71

Showing results (611-620 of 709) with videos related to

Sort By:
Pageof 71
ESMO Open|December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancerO Molinier, B Besse, F Barlesi, et al.
Clinical Lung Cancer|October 26, 2019
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE TrialJaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, et al.
ERJ Open Research|October 13, 2016
Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national surveyVincent Cottin, Emmanuel Bergot, Arnaud Bourdin, et al.
Frontiers in Cell and Developmental Biology|October 28, 2021
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number AlterationsAmira Bouzidi, Karim Labreche, Marine Baron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) programC Leduc, J P Merlio, B Besse, et al.
The European Respiratory Journal|March 17, 2018
Cost-effectiveness of <i>KRAS</i>, <i>EGFR</i> and <i>ALK</i> testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm studySandrine Loubière, Alexandre Drezet, Michèle Beau-Faller, et al.
Frontiers in Immunology|August 10, 2019
Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 PatientsCindy Marques, Julien Carvelli, Lucie Biard, et al.
Respiratory Medicine and Research|May 17, 2020
Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST studyC Fontaine-Delaruelle, J Mazières, J Cadranel, et al.
Exploration of Digestive Diseases|April 9, 2026
Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and TreatmentIna Bergheim, Jean Francois Cadranel, Jian Guo Chen, et al.
Digestive Diseases and Sciences|January 29, 2016
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in FrancePatrick Marcellin, Fabien Zoulim, Christophe Hézode, et al.
Pageof 71